Hossein Jadvar, MD, PhD

Title(s)Professor of Radiology
SchoolKeck School of Medicine of Usc
AddressCSC 102
Health Sciences Campus
Los Angeles CA 90089-9061
Phone+1 323 442 1107
ORCID ORCID Icon0000-0002-9455-2484 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Iowa State University, Ames, IABS06/1982Chemical Engineering
    University of Wisconsin, Madison, WIMS06/1984Biomedical Engineering
    University of Michigan, Ann Arbor, MIMS08/1984Computer, Information and Control Engineering
    University of Michigan, Ann Arbor, MIPhD08/1988Bioengineering
    University of Chicago, Chicago, ILMD06/1993Medicine
    University of California, San Francisco, CACert.06/1994Internal Medicine Clinical Internship
    Stanford University, Stanford, CACert.06/1998Diagnostic Radiology and Nuclear Medicine Residency
    Harvard Medical School, Boston, MACert.06/1999Nuclear Oncology/PET Fellowship
    Harvard Medical School, Boston, MACert.08/2003Clinical Effectiveness Program
    Harvard University, Cambridge, MAMPH08/2005Public Health
    University of Southern California (Marshall School of Business), Los Angeles, CAMBA08/2007Executive Business Administration
    University of Pennsylvania (Wharton School of Business), Philadelphia, PACert.10/2009Executive Leadership
    University of Southern California (Gould School of Law), Los Angeles, CAMSL05/2024Law Studies
    Collapse Awards and Honors
    Office of Education, National Institutes of Health (NIH)1994NIH Resident Research Award
    Radiological Society of North America1997Roentgen Resident/Fellow Research Award
    American College of Nuclear Physicians (ACNP)1998Resident Research Award
    Society of Nuclear Medicine2000 Marc Tetalman Young Investigator Award
    American College of Nuclear Medicine (ACNM)2003Fellow
    IEEE-Engineering in Medicine and Biology Society2006 Senior Member
    USC Center for Excellence in Research2007  - 2010Inaugural Faculty Fellow
    Medical Imaging (MEDI) Review Panel, U.S. National Institutes of Health (NIH)2007  - 2011Charter Member, Medical Imaging Study Section
    PET Clinics and Theranostics (Prostate Cancer)2009Invited Guest Editor
    Western Regional Society of Nuclear Medicine2010Distinguished Scientist Award
    Pasadena Magazine2010  - 2024San Gabriel Valley Top Doctors
    2013  - 2024Best Doctors in America
    Academy for Radiology and Biomedical Imaging Research2014Distinguished Investigator Award
    Journal of Nuclear Medicine (Supplement on Prostate Cancer)2016Invited Guest Editor
    Society of Nuclear Medicine and Molecular Imaging (SNMMI)2016Fellow
    World Association of Radiopharmacutical and Molecular Therapy (WARMTH)2016Prof. Ajit Padhy Memorial Oration Award
    University of Southern California2017Best Mentor Award (Faculty-to-Faculty)
    American College of Nuclear Medicine (ACNM)2018Best Mentor Award
    Society of Nuclear Medicine and Molecular Imaging (SNMMI)2019Peter E. Valk MD Memorial Award
    U.S. Nuclear Regulatory Commission2019  - 2027Advisory Board Member on Medical Uses of Isotopes (Vice Chair 2022-2024, Chair 2024-2027)
    Los Angeles Magazine2020  - 2024Top Doctor (Diagnostic Radiology & Nuclear Medicine)
    Western Regional Society of Nuclear Medicine2020Distinguished Service Award
    University of Southern California2021Certificate of Excellence, USC Keck School of Medicine Center for Equity in Medicine and Science
    American College of Nuclear Medicine (ACNM)2023Lifetime Achievement Award
    Association of Nuclear Physicians of India (ANMPI)2023Prof. RD Lee Oration Award
    Massachusetts General Hospital, Harvard Medical School2024Distinguished Alumnus Award
    USC Department of Radiology2023  - 2024Outstanding Teacher of the Year

    Collapse Overview 
    Collapse Overview
    Hossein Jadvar, MD, PhD, MPH, MBA, MSL, FACNM, FSNMMI
    Professor of Radiology, Urology, and Biomedical Engineering (Tenured)
    University of Southern California, Los Angeles, CA, USA
    Past President, American College of Nuclear Medicine (ACNM)
    Past President, Society of Nuclear Medicine and Molecular Imaging (SNMMI)
    President, SNMMI Therapy Center of Excellence
    Chair, U.S. Nuclear Regulatory Commission Advisory Committee on Medical Uses of Isotopes (NRC-ACMUI)
    Director, American Board of Nuclear Medicine (ABNM)
    Distinguished Investigator, Academy for Radiology and Biomedical Imaging Research


    Dr. Jadvar is currently a tenured Professor of Radiology in the Keck School of Medicine (KSOM), at the University of Southern California (USC), Los Angeles, California, USA. He has joint appointments as Professor of Urology, KSOM, and Professor of Biomedical Engineering, USC Viterbi School of Engineering, and is a full member of the USC Norris Comprehensive Cancer Center. He is the past president and fellow of both the American College of Nuclear Medicine (ACNM) and the Society of Nuclear Medicine and Molecular Imaging (SNMMI). He currently serves as the president of the SNMMI Therapy Center of Excellence.

    Dr. Jadvar immigrated to the United States in 1978 after completing his education at the prestigious Alborz High School in Tehran, Iran. He received the BS degree in chemical engineering from Iowa State University, Ames (1982), MS in biomedical engineering from University of Wisconsin, Madison (1984), MS in computer engineering (1986) and PhD in bioengineering (1988), both from the University of Michigan, Ann Arbor, the MD degree from the University of Chicago Pritzker School of Medicine (1993), Master’s in Public Health (MPH) degree from Harvard University (2005), the Executive Master’s in Business Administration (MBA) from the USC Marshall School of Business (2007, and Master's in Studies of Law (MSL) from the USC Gould School of Law. He was an intern in internal medicine at the University of California San Francisco (UCSF) during 1993-94, a diagnostic radiology and nuclear medicine resident at Stanford University, during 1994-98, and a clinical fellow in nuclear oncology and positron emission tomography (PET) with the Harvard Medical School Joint Program in Nuclear Medicine, during 1998-99. He has completed executive educational certificate programs in clinical effectiveness at Harvard Medical School, and in leadership at the Wharton School of the University of Pennsylvania. He has also attended summer educational enrichment programs at the University of Oxford, UK, and the University of Cambridge, UK.

    He was a Visiting Associate Scientist in Bioengineering at the California Institute of Technology (Caltech) in Pasadena, during 2001-2006. Dr. Jadvar is on the leadership editorial boards of Journal of Nuclear Medicine (Associate Editor), European Journal of Nuclear Medicine and Molecular Imaging (Associate Editor), Radiology (Consultant to the Editor), Theranostics (Associate Editor), and Clinical Nuclear Medicine (Deputy Editor), and is member of the editorial boards of many other peer-reviewed scientific and medical journals. He is the past recipient of the SNMMI Mark Tetalman Young Investigator Award, the Western Regional SNMMI Distinguished Scientist Award and Distinguished Service Award, the Academy for Radiology and Biomedical Imaging Research Distinguished Investigator Award, the inaugural fellowship in the USC Center for Excellence in Research, the inaugural Prof. Ajit Padhy Oration Award from the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), the Prof. RD Lee Oration Award from the Association of Nuclear Physicians of India (ANMPI), the SNMMI PET Center of Excellence Peter E. Valk, MD, Memorial Award, the Best Mentor Awards from both USC and ACNM, the Outstanding Teacher of the Year Award (2023, 2024) from the USC Department of Radiology, the Lifetime Achievement Award from the ACNM, and the Distinguished Alumnus Award from the Massachusetts General Hospital Department of Radiology, Harvard Medical School.

    Dr. Jadvar has been serving since 2019 as the nuclear medicine physician representative on the U.S. Nuclear Regulatory Commission (NRC) Advisory Committee on Medical Uses of Isotopes (ACMUI) and was appointed as the Vice Chair of this Committee in 2022, and as Chair in 2024. He was selected to serve on the Board of Directors of the American Board of Nuclear Medicine (ABNM) in 2023.

    He has been a National Institutes of Health (NIH) funded investigator and serves on multiple NIH review panels (with one term as a chartered member for MEDI study section), and the Department of Defense (DOD) Congressionally Directed Medical Research Programs-Prostate Cancer Research Program, the Department of Energy (DOE) Isotope R&D and Production Program, and the Imaging Technology and Informatics Review Panel of the Cancer Prevention Research Institute of Texas (CPRIT). He has written 182 peer-reviewed journal articles, published 4 books, 40 book chapters, 9 U.S. and European patents, numerous conference abstracts and full articles, and has had more than 350 invited lecturer and visiting professorships at national and international venues. His research interests include translational molecular imaging research with particular current interest in prostate cancer, theranostics, and radiopharmaceutical therapy.

    As of June 15, 2024:
    Web of Science: 260 publications, 4817 citations (18.53 average citations per item), h-index 36
    Google Scholar: 9007 citations, h-index 51, i10 index 130
    ORCID: 0000-0002-9455-2484

    BOOKS
    1. Jadvar H, Parker JA. Clinical PET and PET/CT. Springer-Verlag, Inc., London, UK. 2005. (ISBN 1 85233-838-5)
    2. Jadvar H, Jacene H, Graham M (Eds.). Molecular Imaging: An Introduction. Cambridge University Press, Cambridge, UK. 2017. (ISBN 978-1-107-62128-2)
    3. Jadvar H, Colletti PM (Eds.). Nuclear Medicine: The Essentials. Wolter-Kluwer, Inc., Philadelphia, PA. 2022. (ISBN-13: 978-1-4963-00645)
    4. Gholamrezanejad A, Assadi M, Jadvar H (Eds.). Radiology-Nuclear Medicine Diagnostic Imaging: A Correlative Approach. John Wiley & Sons Ltd., Hoboken, NJ. 2023. (ISBN 9781119603610)

    PATENTS1.
    1. Jadvar H, Arzbaecher RC Artifact Suppressing Apparatus and Method. International Patent #WO/1989/009514, May 10, 1989
    2. Metzger WT, Jadvar H. Variable Stiffness Esophageal Catheter. U.S. Patent #4,930,521, June 5, 1990.
    3. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. European Patent #EP381816A2, August 16, 1990
    4. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. European Patent #EP381816A2, November 7, 1990
    5. Jadvar H, Arzbaecher RC. Method and Apparatus for Detection of Posterior Ischemia. U.S. Patent #5,010,888, April 30, 1991.
    6. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. U.S. Patent #5,069,215, December 3, 1991.
    7. Metzger WT, Jadvar H. Variable Stiffness Esophageal Catheter. European Patent #90905336.5, January 21, 1992.
    8. Jadvar H, Metzger WT. Multiple Electrode Affixable Sheet. U.S. Patent #5,109,851, May 5, 1992.
    9. Metzger WT, Jadvar H. Expandable Esophageal Catheter. U.S. Patent #5,117,828, June 2, 1992.

    Collapse Research 
    Collapse Research Activities and Funding
    Novel Dynamic PET/MRI Evlauation of Treatment Response in Brain Tumors
    The Ming Hsieh Institute No NumberJul 1, 2020 - Aug 31, 2022
    Description: The overall goal of this proposal is to test the hypothesis combined structural, functional, and cellular proliferation imaging information provided by mpMRI and dynamic FMAU PET kinetic analysis more accurately characterize lesions in patients who have undergone primary treatment for brain malignancy.
    Exploiting the immune microenvironment for radiotargeted destruction of leptomeningeal metastases
    NIH/NCI R21CA223325Sep 1, 2018 - Aug 20, 2020
    Role: Co-Investigator
    Exploiting the pro-metastatic effects of chemotherapy for enhanced detection of peritoneal metastases in ovarian cancer
    The Wright Foundation No NumberJul 1, 2018 - Jun 30, 2019
    Role: Co-Investigator
    Pilot Human Studies of FMAU PET in Prostate Cancer
    NIH R21EB017568Sep 4, 2015 - Jun 30, 2021
    Role: Principal Investigator
    Description: No Cost Extension to 06/30/2021
    Disintegrin PET of Prostate Cancer
    Southern California Clinical Translational Science Institute No NumberSep 1, 2014 - Aug 31, 2016
    Role: Principle Investigator
    [F18]FMAU in Prostate Cancer
    NIH R21CA142426Sep 1, 2009 - Aug 31, 2012
    Role: Principal Investigator
    Biomedical imaging informatics training program
    NIH/NIBIB T32EB004308Sep 1, 2005 - Aug 31, 2010
    Role: Co-Investigator
    FDG PET-CT in Metastatic Prostate Cancer
    NIH R01CA111613Aug 12, 2005 - Dec 31, 2013
    Role: Principal Investigator
    Prediction of cardiomyopathy in type 1 diabetes by 31P MRS
    NIH/NHLBI R01HL73412Aug 15, 2002 - Jul 31, 2007
    Role: Co-Investigator
    Pre-clinical study of choline in human prostate cancer xenografts: preliminary data to support in-vivo imaging with choline PET
    The Wright Foundation No NumberJul 1, 2002 - Jun 30, 2004
    Role: Principal Investigator
    Description: No Cost Extension to 06/30/2007
    Role of oxidative metabolism in cancer: validation study with C-14 acetate autoradiography in rats
    Radiological Society of North America No NumberMar 1, 2002
    Role: Principal Investigator
    Discrimination of inflammation from malignancy with dynamic FDG-PET kinetic analysis
    American Cancer Society IRG-58-007-43Jul 1, 2000 - Jun 30, 2002
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Faculty Mentoring
    Collapse Required Scholarly Project Mentor

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PSMA PET AUC Updates: Inclusion of rh-PSMA-7.3. J Nucl Med. 2024 Apr 01; 65(4):540. Hope TA, Jadvar H. PMID: 38176725.
      View in: PubMed   Mentions:    Fields:    
    2. Sequential and Combination Therapies of 223RaCl2 and Prostate-Specific Membrane Antigen Radioligand Therapy. J Nucl Med. 2023 12 01; 64(12):1932-1933. Jadvar H. PMID: 37827840; PMCID: PMC10690120.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. A Life Study in Academic Leadership: A Conversation Between Carolyn C. Meltzer and Hossein Jadvar. J Nucl Med. 2023 08; 64(8):1167-1170. Meltzer CC, Jadvar H. PMID: 37442603.
      View in: PubMed   Mentions:    Fields:    
    4. Clinical Trials of Prostate-Specific Membrane Antigen Radiopharmaceutical Therapy. J Nucl Med Technol. 2023 Mar; 51(1):16-21. Jadvar H, Colletti PM. PMID: 36599704.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Integrating Theranostics Into Patient Care Pathways: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2023 05; 220(5):619-629. O'Shea A, Iravani A, Saboury B, Jadvar H, Catalano O, Mahmood U, Heidari P. PMID: 36321986; PMCID: PMC10133840.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    6. Oligometastatic Prostate Cancer: Current Status and Future Challenges. J Nucl Med. 2022 11; 63(11):1628-1635. Jadvar H, Abreu AL, Ballas LK, Quinn DI. PMID: 36319116; PMCID: PMC9635685.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    7. Tracking Docetaxel-Induced Cellular Proliferation Changes in Prostate Tumor-Bearing Mice with 18F-FMAU PET. Acad Radiol. 2023 08; 30(8):1721-1726. Jadvar H, Park R, Vorobyova I, Chen K. PMID: 36184379; PMCID: PMC10050216.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    8. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association. Circ Cardiovasc Imaging. 2022 Aug; 15(8):e014576. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. PMID: 35920160; PMCID: PMC9384825.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. SNMMI/ACR/ASNC/SCMR Joint Credentialing Statement for Cardiac PET/MRI: Endorsed by the American Heart Association. J Nucl Med. 2023 01; 64(1):149-152. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. PMID: 36599473; PMCID: PMC9841259.
      View in: PubMed   Mentions: 2     Fields:    
    10. SNMMI/ACR/ASNC/SCMR joint credentialing statement for cardiac PET/MRI. J Cardiovasc Magn Reson. 2022 07 19; 24(1):43. Ruddy TD, Al-Mallah M, Arrighi JA, Bois JP, Bluemke DA, Di Carli MF, Dilsizian V, Gropler RJ, Jadvar H, Malhotra S, Pelletier-Galarneau M, Schindler TH, Woodard PK, Chareonthaitawee P. PMID: 35850721; PMCID: PMC9295497.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer. PET Clin. 2022 Jul; 17(3):389-397. Jadvar H, Colletti PM. PMID: 35662493; PMCID: PMC9232915.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer. Radiology. 2022 09; 304(3):609-610. Jadvar H. PMID: 35608452; PMCID: PMC9434807.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer. Mol Imaging Biol. 2022 Dec; 24(6):920-927. Anderson RC, Velez EM, Jadvar H. PMID: 35604526.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Updates to Appropriate Use Criteria for PSMA PET. J Nucl Med. 2022 05; 63(5):14N. Hope TA, Jadvar H. PMID: 35487567.
      View in: PubMed   Mentions: 2     Fields:    
    15. Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center. J Nucl Med. 2022 Dec; 63(12):1836-1843. Herrmann K, Giovanella L, Santos A, Gear J, Ozgen Kiratli P, Kurth J, Denis-Bacelar AM, Hustinx R, Patt M, Wahl RL, Paez D, Giammarile F, Jadvar H, Pandit-Taskar N, Ghesani M, Kunikowska J. PMID: 35450957.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. 2022 06; 49(7):2300-2309. Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, Denis-Bacelar AM, Hustinx R, Patt M, Wahl RL, Paez D, Giammarile F, Jadvar H, Pandit-Taskar N, Ghesani M, Kunikowska J. PMID: 35403861; PMCID: PMC9165261.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    17. The VISION Forward: Recognition and Implication of PSMA-/18F-FDG+ mCRPC. J Nucl Med. 2022 06; 63(6):812-815. Jadvar H. PMID: 34933889; PMCID: PMC9157736.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    18. Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. J Nucl Med. 2022 01; 63(1):59-68. Jadvar H, Calais J, Fanti S, Feng F, Greene KL, Gulley JL, Hofman M, Koontz BF, Lin DW, Morris MJ, Rowe SP, Royce TJ, Salami S, Savir-Baruch B, Srinivas S, Hope TA. PMID: 34593595; PMCID: PMC8717184.
      View in: PubMed   Mentions: 20     Fields:    
    19. Author Correction: Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Sep 14; 4(1):139. Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. PMID: 34521985; PMCID: PMC8440668.
      View in: PubMed   Mentions: 1  
    20. Low-count whole-body PET with deep learning in a multicenter and externally validated study. NPJ Digit Med. 2021 Aug 23; 4(1):127. Chaudhari AS, Mittra E, Davidzon GA, Gulaka P, Gandhi H, Brown A, Zhang T, Srinivas S, Gong E, Zaharchuk G, Jadvar H. PMID: 34426629; PMCID: PMC8382711.
      View in: PubMed   Mentions: 25  
    21. 18F-FDG PET/CT Monitoring of Response to Programmed Death Protein 1 Blockade in Metastatic Basal Cell Carcinoma. Clin Nucl Med. 2021 Aug 01; 46(8):e436-e437. Jadvar H, In GK. PMID: 33512957; PMCID: PMC8243770.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    22. Targeted α-therapy in non-prostate malignancies. Eur J Nucl Med Mol Imaging. 2021 12; 49(1):47-53. Jadvar H, Colletti PM. PMID: 33993386.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Competitive Advantage of PSMA Theranostics in Prostate Cancer. Radiology. 2021 05; 299(2):261-263. Jadvar H. PMID: 33788590; PMCID: PMC8103912.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2021 04; 216(4):851-859. Savir-Baruch B, Choyke PL, Rowe SP, Schuster DM, Subramaniam RM, Jadvar H. PMID: 33206564.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    25. Management Impact of 68Ga-DOTATATE PET/CT in Neuroendocrine Tumors. Nucl Med Mol Imaging. 2021 Feb; 55(1):31-37. Anderson RC, Velez EM, Desai B, Jadvar H. PMID: 33643487; PMCID: PMC7881063.
      View in: PubMed   Mentions: 2  
    26. PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. J Cancer Res Clin Oncol. 2021 Jun; 147(6):1803-1811. In GK, Vaidya P, Filkins A, Hermel DJ, King KG, Ragab O, Tseng WW, Swanson M, Kokot N, Lang JE, Menendez L, DeClerck B, Kim G, Hu JC, Terando A, Jadvar H, Ricker C, Miller KA, Peng DH, Wysong A. PMID: 33210210.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    27. Invited Commentary: Nuclear Theranostics-The Path Forward. Radiographics. 2020 10; 40(6):1741-1742. Greenspan BS, Jadvar H. PMID: 33016813.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Salvage Therapies After 18F-Fluciclovine Detected Prostate Cancer Recurrences. Clin Nucl Med. 2020 Sep; 45(9):668-671. Hwang L, Paluch J, Jadvar H, England JR, Desai B, Ballas LK. PMID: 32520496.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Prostate Cancer Lymphangitic Pulmonary Carcinomatosis: Appearance on 18F-FDG PET/CT and 18F-DCFPyL PET/CT. Clin Nucl Med. 2020 Sep; 45(9):727-729. Zukotynski KA, Jadvar H, Potvin K, Cho SY, Kim CK, Winquist E. PMID: 32520499.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. Appropriate Use Criteria for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer After Definitive Primary Treatment. J Nucl Med. 2020 04; 61(4):552-562. Jadvar H, Ballas LK, Choyke PL, Fanti S, Gulley JL, Herrmann K, Hope TA, Klitzke AK, Oldan JD, Pomper MG, Rowe SP, Subramaniam RM, Taneja SS, Vargas HA, Ahuja S. PMID: 32238495.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    31. A review of prostate cancer imaging, positron emission tomography, and radiopharmaceutical-based therapy. Can Urol Assoc J. 2020 Apr; 14(4):130-138. Pawson A, Ghumman Z, Kuo PH, Jadvar H, Bartel T, Shayegan B, Zukotynski K. PMID: 32254013; PMCID: PMC7124170.
      View in: PubMed   Mentions: 1  
    32. Targeted α-Therapy in Cancer Management: Synopsis of Preclinical and Clinical Studies. Cancer Biother Radiopharm. 2020 Sep; 35(7):475-484. Jadvar H. PMID: 32202923; PMCID: PMC7475102.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    33. Comparative prognostic implication of treatment response assessments in mCRPC: PERCIST 1.0, RECIST 1.1, and PSA response criteria. Theranostics. 2020; 10(7):3254-3262. Velez EM, Desai B, Ji L, Quinn DI, Colletti PM, Jadvar H. PMID: 32194866; PMCID: PMC7053201.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    34. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO Guideline. J Clin Oncol. 2020 06 10; 38(17):1963-1996. Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, Rosenkrantz AB, Verma S, Margolis DJ, Froemming A, Oto A, Purysko A, Milowsky MI, Schlemmer HP, Eiber M, Morris MJ, Choyke PL, Padhani A, Oldan J, Fanti S, Jain S, Pinto PA, Keegan KA, Porter CR, Coleman JA, Bauman GS, Jani AB, Kamradt JM, Sholes W, Vargas HA. PMID: 31940221.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    35. Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer. Amino Acids. 2019 Nov; 51(10-12):1569-1575. Jadvar H, Chen K, Park R, Yap LP, Vorobyova I, Swenson S, Markland FS. PMID: 31621030; PMCID: PMC6881555.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    36. 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial. Lancet Oncol. 2019 09; 20(9):1286-1294. Calais J, Ceci F, Eiber M, Hope TA, Hofman MS, Rischpler C, Bach-Gansmo T, Nanni C, Savir-Baruch B, Elashoff D, Grogan T, Dahlbom M, Slavik R, Gartmann J, Nguyen K, Lok V, Jadvar H, Kishan AU, Rettig MB, Reiter RE, Fendler WP, Czernin J. PMID: 31375469; PMCID: PMC7469487.
      View in: PubMed   Mentions: 136     Fields:    Translation:HumansCTClinical Trials
    37. Editorial Comment. J Urol. 2019 08; 202(2):420-421. Luis de Castro Abreu A, Jadvar H. PMID: 31094671.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    38. Treatment Response Assessment of Skeletal Metastases in Prostate Cancer with 18F-NaF PET/CT. Nucl Med Mol Imaging. 2019 Aug; 53(4):247-252. Velez EM, Desai B, Jadvar H. PMID: 31456857; PMCID: PMC6694323.
      View in: PubMed   Mentions: 6  
    39. Gallium-68-Labeled Prostate-Specific Membrane Antigen-11 PET/CT of Prostate and Nonprostate Cancers. AJR Am J Roentgenol. 2019 08; 213(2):286-299. Osmany S, Zaheer S, Bartel TB, Johnston M, Peh WM, Barmaky S, Jadvar H. PMID: 31166760; PMCID: PMC7469486.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Prediction of Time to Hormonal Treatment Failure in Metastatic Castration-Sensitive Prostate Cancer with 18F-FDG PET/CT. J Nucl Med. 2019 11; 60(11):1524-1530. Jadvar H, Velez EM, Desai B, Ji L, Colletti PM, Quinn DI. PMID: 30926649; PMCID: PMC6836859.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    41. 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment. Clin Nucl Med. 2019 Mar; 44(3):e128-e132. England JR, Paluch J, Ballas LK, Jadvar H. PMID: 30589673; PMCID: PMC7467752.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    42. Management of Primary Osseous Spinal Tumors with PET. PET Clin. 2019 Jan; 14(1):91-101. Batouli A, Gholamrezanezhad A, Petrov D, Rudkin S, Matcuk G, Jadvar H. PMID: 30420225; PMCID: PMC7466826.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer. Eur J Nucl Med Mol Imaging. 2019 01; 46(1):8-10. Jadvar H. PMID: 30310953; PMCID: PMC7469941.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. PET in the Diagnostic Management of Soft Tissue Sarcomas of Musculoskeletal Origin. PET Clin. 2018 Oct; 13(4):609-621. Katal S, Gholamrezanezhad A, Kessler M, Olyaei M, Jadvar H. PMID: 30219191; PMCID: PMC7466822.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    45. Applications of PET/CT and PET/MR Imaging in Primary Bone Malignancies. PET Clin. 2018 Oct; 13(4):623-634. Behzadi AH, Raza SI, Carrino JA, Kosmas C, Gholamrezanezhad A, Basques K, Matcuk GR, Patel J, Jadvar H. PMID: 30219192; PMCID: PMC7466825.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    46. Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors. Mol Imaging Biol. 2018 08; 20(4):501-509. Baratto L, Jadvar H, Iagaru A. PMID: 29256046; PMCID: PMC7469490.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    47. Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology. J Nucl Med. 2018 09; 59(9):1338-1339. Jadvar H. PMID: 30030344; PMCID: PMC6126444.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Incidental Detection of Meningioma by 18F-FMAU PET/CT in a Patient With Suspected Prostate Cancer. Clin Nucl Med. 2018 Jul; 43(7):e245-e246. Varghese B, Velez E, Desai B, Jadvar H. PMID: 29742600; PMCID: PMC5980759.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases. Clin Nucl Med. 2018 Jul; 43(7):e226-e231. Chau A, Gardiner P, Colletti PM, Jadvar H. PMID: 29762238; PMCID: PMC5980771.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    50. Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging. AJR Am J Roentgenol. 2018 Jun; 210(6):W245-W263. Gholamrezanezhad A, Basques K, Batouli A, Matcuk G, Alavi A, Jadvar H. PMID: 29787313; PMCID: PMC7469956.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    51. 18F-NaF/223RaCl2 theranostics in metastatic prostate cancer: treatment response assessment and prediction of outcome. Br J Radiol. 2018 Nov; 91(1091):20170948. Jadvar H, Colletti PM. PMID: 29630398; PMCID: PMC6475949.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Point: The Existential Threat to Nuclear Medicine. J Am Coll Radiol. 2018 03; 15(3 Pt A):384-386. Graham MM, Delbeke D, Jadvar H. PMID: 29502649.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Reply: Staging, Restaging, and Treatment Response Assessment in Lymphomas: What We Should Know. J Nucl Med. 2018 04; 59(4):715-716. Delgado-Bolton R, Esposito G, Colletti PM, Jadvar H. PMID: 29419476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    54. Radiotheranostics in Cancer Diagnosis and Management. Radiology. 2018 02; 286(2):388-400. Jadvar H, Chen X, Cai W, Mahmood U. PMID: 29356634; PMCID: PMC5790308.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    55. The First Theranostic Conference at the American University of Beirut Medical Center. J Nucl Med. 2018 01; 59(1):13N. Jadvar H. PMID: 29295944.
      View in: PubMed   Mentions:    Fields:    
    56. SNMMI Scientific Delegation to Cuba. J Nucl Med. 2018 01; 59(1):15N. Jadvar H. PMID: 29295946.
      View in: PubMed   Mentions:    Fields:    
    57. PSMA Theranostics: Current Status and Future Directions. Mol Imaging. 2018 Jan-Dec; 17:1536012118776068. Rahbar K, Afshar-Oromieh A, Jadvar H, Ahmadzadehfar H. PMID: 29873291; PMCID: PMC5992796.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    58. PSMA PET: Transformational Change in Prostate Cancer Management? J Nucl Med. 2018 02; 59(2):228-229. Jadvar H, Ballas LK. PMID: 29242400.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. Non-oncologic Applications of PET/CT and PET/MR in Musculoskeletal, Orthopedic, and Rheumatologic Imaging: General Considerations, Techniques, and Radiopharmaceuticals. J Nucl Med Technol. 2017 Nov 10. Gholamrezanezhad A, Basques K, Batouli A, Olyaie M, Matcuk G, Alavi A, Jadvar H. PMID: 29127246.
      View in: PubMed   Mentions: 3     Fields:    
    60. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 11; 18(11):e653-e706. Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. PMID: 29208398; PMCID: PMC6178838.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    61. Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. J Nucl Med. 2017 12; 58(12):2026-2037. Jadvar H, Colletti PM, Delgado-Bolton R, Esposito G, Krause BJ, Iagaru AH, Nadel H, Quinn DI, Rohren E, Subramaniam RM, Zukotynski K, Kauffman J, Ahuja S, Griffeth L. PMID: 29025980.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    62. Highlights of articles published in annals of nuclear medicine 2016. Eur J Nucl Med Mol Imaging. 2017 Oct; 44(11):1928-1933. Jadvar H. PMID: 28752226; PMCID: PMC5709218.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity. Diagnostics (Basel). 2017 Jul 20; 7(3). Jadvar H. PMID: 28726731; PMCID: PMC5617943.
      View in: PubMed   Mentions: 2  
    64. Prostate-Specific Antigen and Prostate-Specific Antigen Kinetics in Predicting 18F-Sodium Fluoride Positron Emission Tomography-Computed Tomography Positivity for First Bone Metastases in Patients with Biochemical Recurrence after Radical Prostatectomy. World J Nucl Med. 2017 Jul-Sep; 16(3):229-236. Yoon J, Ballas L, Desai B, Jadvar H. PMID: 28670183; PMCID: PMC5460308.
      View in: PubMed   Mentions: 2  
    65. ACR and SNMMI Joint Credentialing Statement for PET/MRI of the Body. J Nucl Med. 2017 07; 58(7):1174-1176. Subramaniam RM, Jadvar H, Colletti PM, Guimaraes A, Gullapali R, Iagaru AH, McConathy J, Meltzer CC, Nadel H, Noto RB, Packard AB, Rohren EM, Oates ME. PMID: 28473601.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    66. Targeted Radionuclide Therapy: An Evolution Toward Precision Cancer Treatment. AJR Am J Roentgenol. 2017 Aug; 209(2):277-288. Jadvar H. PMID: 28463538; PMCID: PMC5565155.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    67. Multimodal Imaging in Focal Therapy Planning and Assessment in Primary Prostate Cancer. Clin Transl Imaging. 2017 Jun; 5(3):199-208. Jadvar H. PMID: 28713796; PMCID: PMC5508749.
      View in: PubMed   Mentions: 1  
    68. Science to Practice: Does FDG Differentiate Morphologically Unstable from Stable Atherosclerotic Plaque? Radiology. 2017 Apr; 283(1):1-3. Dilsizian V, Jadvar H. PMID: 28318446.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    69. Effect of Androgen on Normal Biodistribution of [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in Athymic Non-tumor-bearing Male Mice. Anticancer Res. 2017 02; 37(2):475-479. Jadvar H, Park R, Yap LP, Chen K, Hughes L, Conti P. PMID: 28179292; PMCID: PMC5404414.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    70. Radiotheranostics in Prostate Cancer: Introduction and Overview. J Nucl Med. 2016 10; 57(Suppl 3):1S-2S. Jadvar H. PMID: 27694166.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    71. Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer. J Nucl Med. 2016 Oct; 57(Suppl 3):19S-24S. Iagaru AH, Mittra E, Colletti PM, Jadvar H. PMID: 27694165; PMCID: PMC5093914.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    72. PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer. J Nucl Med. 2016 Oct; 57(Suppl 3):25S-29S. Jadvar H. PMID: 27694167; PMCID: PMC5093915.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    73. SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer. J Nucl Med. 2017 01; 58(1):11-12. Zukotynski K, Jadvar H, Hope T, Subramaniam RM, Van Loon K, Varma M, Niederkohr RD, PET Center of Excellence. PMID: 27688471.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    74. Is There Use for FDG-PET in Prostate Cancer? Semin Nucl Med. 2016 11; 46(6):502-506. Jadvar H. PMID: 27825430; PMCID: PMC5119923.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    75. Pathways to the Future of Nuclear Medicine Task Force: Phase 1 Report. J Nucl Med. 2016 09; 57(9):17N-9N. Jadvar H, Nuclear Medicine Stakeholders. PMID: 27587796.
      View in: PubMed   Mentions: 1     Fields:    
    76. Duplex Doppler sonography: is there clinical relevance to elevated renal vein velocity in kidney transplants? Clin Imaging. 2016 Nov - Dec; 40(6):1237-1245. Gulati M, Palmer SL, Im MY, Jadvar H, Qazi YA, Fazli U, Grant EG. PMID: 27618805.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Update on advances in molecular PET in urological oncology. Jpn J Radiol. 2016 Jul; 34(7):470-85. Kitajima K, Yamamoto S, Fukushima K, Minamimoto R, Kamai T, Jadvar H. PMID: 27222021; PMCID: PMC5412592.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    78. Targeted Radionuclide Therapy: Practical Applications and Future Prospects. Biomark Cancer. 2016; 8(Suppl 2):35-8. Zukotynski K, Jadvar H, Capala J, Fahey F. PMID: 27226737; PMCID: PMC4874742.
      View in: PubMed   Mentions: 18  
    79. Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer. Abdom Radiol (NY). 2016 05; 41(5):889-98. Jadvar H. PMID: 27193789; PMCID: PMC5412588.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    80. SNMMI Leadership Update: Pathways to the Future of Nuclear Medicine. J Nucl Med. 2016 Apr; 57(4):15N. Jadvar H. PMID: 27037354.
      View in: PubMed   Mentions:    Fields:    
    81. SNMMI Leadership Update: Developing Evidence-Based Appropriate Use Criteria under the Protecting Access to Medicare Act of 2014. J Nucl Med. 2015 Nov; 56(11):20N. Jadvar H. PMID: 26526797.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    82. Positron Emission Tomography in Prostate Cancer: Summary of Systematic Reviews and Meta-Analysis. Tomography. 2015 Sep; 1(1):18-22. Jadvar H. PMID: 26726317; PMCID: PMC4696775.
      View in: PubMed   Mentions: 11     Fields:    
    83. Targeted Prostate Gland Biopsy With Combined Transrectal Ultrasound, mpMRI, and 18F-FMAU PET/CT. Clin Nucl Med. 2015 Aug; 40(8):e426-8. Jadvar H, Chen K, Ukimura O. PMID: 26018690; PMCID: PMC4494895.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    84. Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy. J Nucl Med. 2015 Jul; 56(7):1119-29. Fahey F, Zukotynski K, Jadvar H, Capala J, organizing committee, contributors, and participants of the second NCI–SNMMI Workshop on Targeted Ra. PMID: 25999432.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    85. PSMA PET in Prostate Cancer. J Nucl Med. 2015 Aug; 56(8):1131-2. Jadvar H. PMID: 25977465; PMCID: PMC7477922.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    86. One-Year Postapproval Clinical Experience with Radium-223 Dichloride in Patients with Metastatic Castrate-Resistant Prostate Cancer. Cancer Biother Radiopharm. 2015 Jun; 30(5):195-9. Jadvar H, Challa S, Quinn DI, Conti PS. PMID: 25746633; PMCID: PMC4492702.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    87. American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain. J Nucl Med. 2015 Apr; 56(4):642-5. Jadvar H, Subramaniam RM, Berman CG, Boada F, Colletti PM, Guimaraes AR, McConathy J, Meltzer CC, Noto RB, Packard AB, Rohren EM, Oates ME. PMID: 25745088; PMCID: PMC4465538.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    88. Association of overall survival with glycolytic activity of castrate-resistant prostate cancer metastases. Radiology. 2015 Feb; 274(2):624-5. Jadvar H, Groshen SG, Quinn DI. PMID: 25625748.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    89. Prognostic Utility of PET in Prostate Cancer. PET Clin. 2015 Apr; 10(2):255-63. Jadvar H. PMID: 25829090; PMCID: PMC4382583.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    90. Imaging Cellular Proliferation in Prostate Cancer with Positron Emission Tomography. Asia Ocean J Nucl Med Biol. 2015; 3(2):72-6. Jadvar H. PMID: 27408885; PMCID: PMC4937643.
      View in: PubMed   Mentions: 6  
    91. Sodium 18F-fluoride PET/CT of bone, joint, and other disorders. Semin Nucl Med. 2015 Jan; 45(1):58-65. Jadvar H, Desai B, Conti PS. PMID: 25475379; PMCID: PMC4258001.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    92. Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature. Am J Nucl Med Mol Imaging. 2014; 4(6):580-601. Yu CY, Desai B, Ji L, Groshen S, Jadvar H. PMID: 25250207; PMCID: PMC4171844.
      View in: PubMed   Mentions: 38  
    93. SNMMI comment on ASCO 2013 "Choosing wisely" recommendation on use of PET/CT in recurrent cancer surveillance. J Nucl Med. 2014 May; 55(5):699-700. Rohren EM, Dillehay GL, Jadvar H. PMID: 24665086.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. The SNMMI and EANM practice guideline for tele-nuclear medicine 2.0. J Nucl Med Technol. 2014 Mar; 42(1):15-9. Parker JA, Christian P, Jadvar H, Sattler B, Wallis JW. PMID: 24375155.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansPHPublic Health
    95. Targeted α-particle therapy of bone metastases in prostate cancer. Clin Nucl Med. 2013 Dec; 38(12):966-71. Jadvar H, Quinn DI. PMID: 24212441; PMCID: PMC3874447.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    96. Molecular imaging of prostate cancer with PET. J Nucl Med. 2013 Oct; 54(10):1685-8. Jadvar H. PMID: 24084704.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    97. Baseline 18F-FDG PET/CT parameters as imaging biomarkers of overall survival in castrate-resistant metastatic prostate cancer. J Nucl Med. 2013 Aug; 54(8):1195-201. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Pinski JK, Quinn DI. PMID: 23785174; PMCID: PMC3783857.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    98. Competitive advantage of PET/MRI. Eur J Radiol. 2014 Jan; 83(1):84-94. Jadvar H, Colletti PM. PMID: 23791129; PMCID: PMC3800216.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    99. Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations. Eur J Nucl Med Mol Imaging. 2013 Jul; 40 Suppl 1:S5-10. Jadvar H. PMID: 23429934; PMCID: PMC3681838.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    100. [18F]-2'-Fluoro-5-methyl-1-beta-D-arabinofuranosyluracil (18F-FMAU) in prostate cancer: initial preclinical observations. Mol Imaging. 2012 Sep-Oct; 11(5):426-32. Jadvar H, Yap LP, Park R, Li Z, Chen K, Hughes L, Kouhi A, Conti P. PMID: 22954187; PMCID: PMC3443080.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    101. Molecular imaging of prostate cancer: PET radiotracers. AJR Am J Roentgenol. 2012 Aug; 199(2):278-91. Jadvar H. PMID: 22826388; PMCID: PMC3408965.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    102. PET/CT in prostate cancer: non-choline radiopharmaceuticals. Q J Nucl Med Mol Imaging. 2012 Aug; 56(4):367-74. Castellucci P, Jadvar H. PMID: 23013666; PMCID: PMC3468297.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    103. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med. 2012 Oct; 53(10):1633-51. Silberstein EB, Alavi A, Balon HR, Clarke SE, Divgi C, Gelfand MJ, Goldsmith SJ, Jadvar H, Marcus CS, Martin WH, Parker JA, Royal HD, Sarkar SD, Stabin M, Waxman AD. PMID: 22787108.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    104. Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer. Clin Nucl Med. 2012 Jul; 37(7):637-43. Jadvar H, Desai B, Ji L, Conti PS, Dorff TB, Groshen SG, Gross ME, Pinski JK, Quinn DI. PMID: 22691503; PMCID: PMC3375600.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCTClinical Trials
    105. Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers. Semin Nucl Med. 2012 Jul; 42(4):247-54. Jadvar H. PMID: 22681673.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    106. FDG-PET/MRI fusion demonstrating cricoarytenoid muscle hypermetabolism due to contralateral true vocal cord paralysis. Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec; 31(6):362-3. Lu D, Jadvar H, Go J, Henderson R, Boyko O, Grant E, Law M. PMID: 23084020.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    107. Multimodality imaging in biochemical recurrence of prostate cancer: utility of (18)F-NaF PET/CT in early detection of metastasis. Rev Esp Med Nucl Imagen Mol. 2012 Jul-Aug; 31(4):231-2. Desai B, Gross ME, Jadvar H. PMID: 22980132; PMCID: PMC3458514.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    108. Preservation of retinotopic map in retinal degeneration. Exp Eye Res. 2012 May; 98:88-96. Xie J, Wang GJ, Yow L, Humayun MS, Weiland JD, Cela CJ, Jadvar H, Lazzi G, Dhrami-Gavazi E, Tsang SH. PMID: 22685713; PMCID: PMC4310463.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. Can Choline PET Tackle the Challenge of Imaging Prostate Cancer? Theranostics. 2012; 2(3):331-2. Jadvar H. PMID: 22448199; PMCID: PMC3311231.
      View in: PubMed   Mentions: 4     Fields:    
    110. FDG PET/CT demonstration of pancreatic metastasis from prostate cancer. Clin Nucl Med. 2011 Oct; 36(10):961-2. Desai B, Elatre W, Quinn DI, Jadvar H. PMID: 21892064; PMCID: PMC3167095.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    111. Colonic FDG uptake pattern in subjects receiving oral contrast with no known or suspected colonic disease. Clin Nucl Med. 2011 Sep; 36(9):754-6. Jadvar H. PMID: 21825842.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    112. ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. Clin Nucl Med. 2011 Aug; 36(8):e72-80. Henkin RE, Del Rowe JD, Grigsby PW, Hartford AC, Jadvar H, Macklis RM, Parker JA, Wong JY, Rosenthal SA. PMID: 21716005.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    113. Prostate cancer. Methods Mol Biol. 2011; 727:265-90. Jadvar H. PMID: 21331939.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    114. Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline. J Nucl Med. 2011 Jan; 52(1):81-9. Jadvar H. PMID: 21149473; PMCID: PMC3012154.
      View in: PubMed   Mentions: 108     Fields:    Translation:Humans
    115. Evolving cardiac conduction phenotypes in developing zebrafish larvae: implications to drug sensitivity. Zebrafish. 2010 Dec; 7(4):325-31. Yu F, Huang J, Adlerz K, Jadvar H, Hamdan MH, Chi N, Chen JN, Hsiai TK. PMID: 20958244; PMCID: PMC3005146.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    116. Modeling and percept of transcorneal electrical stimulation in humans. IEEE Trans Biomed Eng. 2011 Jul; 58(7):1932-9. Xie J, Wang GJ, Yow L, J Cela C, Humayun MS, Weiland JD, Lazzi G, Jadvar H. PMID: 20952323.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    117. The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo. Prostate. 2010 Sep 01; 70(12):1359-70. Lin E, Wang Q, Swenson S, Jadvar H, Groshen S, Ye W, Markland FS, Pinski J. PMID: 20623636.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    118. Influence of trigger PSA and PSA kinetics on (11)C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med. 2010 Mar; 51(3):498-9; author reply 499-500. Jadvar H. PMID: 20150273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    119. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med. 2009 Nov; 50(11):1820-7. Jadvar H, Alavi A, Gambhir SS. PMID: 19837767; PMCID: PMC2783751.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansAnimals
    120. Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET. Nat Rev Urol. 2009 Jun; 6(6):317-23. Jadvar H. PMID: 19434102; PMCID: PMC2734968.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    121. FDG PET in Prostate Cancer. PET Clin. 2009 Apr 01; 4(2):155-61. Jadvar H. PMID: 20161051; PMCID: PMC2746691.
      View in: PubMed   Mentions: 21     Fields:    
    122. Role of Imaging in Prostate Cancer. PET Clin. 2009 Apr 01; 4(2):135-8. Jadvar H, Alavi A. PMID: 20161047; PMCID: PMC2746671.
      View in: PubMed   Mentions: 5     Fields:    
    123. Preface. PET Clin. 2009 Apr; 4(2):ix. Jadvar H. PMID: 27157012.
      View in: PubMed   Mentions:    Fields:    
    124. Molecular imaging of prostate cancer: a concise synopsis. Mol Imaging. 2009 Mar-Apr; 8(2):56-64. Jadvar H. PMID: 19397851; PMCID: PMC2688393.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    125. Evaluation by 18F-FDG-PET of patients with anal squamous cell carcinoma. Hell J Nucl Med. 2009 Jan-Apr; 12(1):26-9. Iagaru A, Kundu R, Jadvar H, Nagle D. PMID: 19330178.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    126. [F-18]-fluorodeoxyglucose PET-CT of the normal prostate gland. Ann Nucl Med. 2008 Nov; 22(9):787-93. Jadvar H, Ye W, Groshen S, Conti PS. PMID: 19039557; PMCID: PMC2636719.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    127. Choline autoradiography of human prostate cancer xenograft: effect of castration. Mol Imaging. 2008 May-Jun; 7(3):147-52. Jadvar H, Gurbuz A, Li X, Shahinian A, Conti PS. PMID: 19123985; PMCID: PMC2621313.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    128. [F-18]-Fluorodeoxyglucose PET and PET-CT in diagnostic imaging evaluation of locally recurrent and metastatic bladder transitional cell carcinoma. Int J Clin Oncol. 2008 Feb; 13(1):42-7. Jadvar H, Quan V, Henderson RW, Conti PS. PMID: 18307018; PMCID: PMC2295284.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    129. PET and PET/CT in pediatric oncology. Semin Nucl Med. 2007 Sep; 37(5):316-31. Jadvar H, Connolly LP, Fahey FH, Shulkin BL. PMID: 17707239.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    130. A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. Eur J Radiol. 2008 Mar; 65(3):449-61. Janne d'Othée B, Siebert U, Cury R, Jadvar H, Dunn EJ, Hoffmann U. PMID: 17590554.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    131. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. J Comput Assist Tomogr. 2007 Mar-Apr; 31(2):223-8. Jadvar H, Henderson RW, Conti PS. PMID: 17414758.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    132. Adenocarcinoma in an Indiana pouch on PET-CT. Clin Nucl Med. 2007 Jan; 32(1):57-8. Ho L, Henderson R, Jadvar H. PMID: 17179810.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    133. Actinomycosis mimicking anastomotic recurrent esophageal cancer on PET-CT. Clin Nucl Med. 2006 Oct; 31(10):646-7. Ho L, Seto J, Jadvar H. PMID: 16985378.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    134. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer. Mol Imaging Biol. 2006 May-Jun; 8(3):193-200. Jadvar H, Henderson RW, Conti PS. PMID: 16565910.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    135. FDG PET-CT demonstration of Sjogren's sialoadenitis. Clin Nucl Med. 2005 Oct; 30(10):698-9. Jadvar H, Bonyadlou S, Iagaru A, Colletti PM. PMID: 16166849.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    136. Glucose metabolism of human prostate cancer mouse xenografts. Mol Imaging. 2005 Apr-Jun; 4(2):91-7. Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, Conti PS. PMID: 16105512.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimals
    137. PET in pediatric diseases. Radiol Clin North Am. 2005 Jan; 43(1):135-52. Jadvar H, Alavi A, Mavi A, Shulkin BL. PMID: 15693653.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    138. The reproductive tract. Semin Nucl Med. 2004 Oct; 34(4):262-73. Jadvar H, Conti PS. PMID: 15493004.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    139. Musculoskeletal system. Semin Nucl Med. 2004 Oct; 34(4):254-61. Jadvar H, Gamie S, Ramanna L, Conti PS. PMID: 15493003.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    140. Fusion positron emission tomography-computed tomography demonstration of epidural metastases. Clin Nucl Med. 2004 Jan; 29(1):39-40. Jadvar H, Cham D, Gamie S, Henderson RW. PMID: 14688597.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    141. Electrocardiographic characterization of embryonic zebrafish. Conf Proc IEEE Eng Med Biol Soc. 2004; 2004:3615-7. Forouhar AS, Hove JR, Calvert C, Flores J, Jadvar H, Gharib M. PMID: 17271074.
      View in: PubMed   Mentions: 16     Fields:    
    142. Diagnostic role of [F-18]-FDG positron emission tomography in restaging renal cell carcinoma. Clin Nephrol. 2003 Dec; 60(6):395-400. Jadvar H, Kherbache HM, Pinski JK, Conti PS. PMID: 14690256.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    143. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep. 2003 Sep-Oct; 10(5):1485-8. Jadvar H, Pinski JK, Conti PS. PMID: 12883728.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    144. Evaluation of recurrent gastric malignancy with [F-18]-FDG positron emission tomography. Clin Radiol. 2003 Mar; 58(3):215-21. Jadvar H, Tatlidil R, Garcia AA, Conti PS. PMID: 12639527.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    145. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol. 2002 Dec; 31(12):690-4. Jadvar H, Conti PS. PMID: 12483429.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    146. Pharmacologic interventions in nuclear radiology: indications, imaging protocols, and clinical results. Radiographics. 2002 May-Jun; 22(3):477-90. Saremi F, Jadvar H, Siegel ME. PMID: 12006682.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    147. Evaluation of pancreatic carcinoma with FDG PET. Abdom Imaging. 2001 May-Jun; 26(3):254-9. Jadvar H, Fischman AJ. PMID: 11429948.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    148. Non-visualization of sentinel lymph node in patients with breast cancer. Nucl Med Commun. 2001 Jan; 22(1):25-32. Krausz Y, Ikeda DM, Jadvar H, Langleben D, Birdwell R, Strauss HW. PMID: 11233548.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    149. Comparison of fluorine-18 deoxyglucose and O-15 water PET in temporal lobe epilepsy. Acta Neurol Belg. 2000 Dec; 100(4):214-20. Tatlidil R, Luther S, West A, Jadvar H, Kingman T. PMID: 11233675.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    150. Medical imaging in microgravity. Aviat Space Environ Med. 2000 Jun; 71(6):640-6. Jadvar H. PMID: 10870824.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    151. The effect of fluorine-18 fluorodeoxyglucose positron emission tomography on the management of cutaneous malignant melanoma. Clin Nucl Med. 2000 Jan; 25(1):48-51. Jadvar H, Johnson DL, Segall GM. PMID: 10634531.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    152. Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose. Clin Nucl Med. 1999 Dec; 24(12):965-7. Jadvar H, Schambye RB, Segall GM. PMID: 10595478.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    153. Physiologic Source of Intestinal FDG Uptake. Effect of Atropine and Sincalide. Clin Positron Imaging. 1999 Nov; 2(6):318. Jadvar H, Schambye RB, Segall GM. PMID: 14516615.
      View in: PubMed   Mentions:
    154. SPECT and PET in the evaluation of coronary artery disease. Radiographics. 1999 Jul-Aug; 19(4):915-26. Jadvar H, Strauss HW, Segall GM. PMID: 10464799.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    155. Evaluation of Rare Tumors with [F-18]Fluorodeoxyglucose Positron Emission Tomography. Clin Positron Imaging. 1999 May; 2(3):153-158. Jadvar H, Fischman AJ. PMID: 14516539.
      View in: PubMed   Mentions: 8  
    156. Annular pancreas in adults: imaging features in seven patients. Abdom Imaging. 1999 Mar-Apr; 24(2):174-7. Jadvar H, Mindelzun RE. PMID: 10024406.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    157. Role of FDG PET in the Evaluation of Rare Tumors. Clin Positron Imaging. 1998 Sep; 1(4):239. Jadvar H, Parker JA, Fischman AJ. PMID: 14516562.
      View in: PubMed   Mentions:
    158. Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography. Nucl Med Commun. 1998 Jun; 19(6):547-54. Jadvar H, McDougall IR, Segall GM. PMID: 10234658.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    159. Effect of radionuclide renograms on treatment of patients with spinal cord injuries. AJR Am J Roentgenol. 1997 Oct; 169(4):1045-7. Phillips JR, Jadvar H, Sullivan G, Lin VW, Segall GM. PMID: 9308462.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    160. False-negative fluorine-18-FDG PET in metastatic carcinoid. J Nucl Med. 1997 Sep; 38(9):1382-3. Jadvar H, Segall GM. PMID: 9293792.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    161. Still the great mimicker: abdominal tuberculosis. AJR Am J Roentgenol. 1997 Jun; 168(6):1455-60. Jadvar H, Mindelzun RE, Olcott EW, Levitt DB. PMID: 9168707.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    162. Computer analysis of the electrocardiogram during esophageal pacing cardiac stress. IEEE Trans Biomed Eng. 1991 Nov; 38(11):1089-99. Jadvar H, Jenkins JM, Stewart RE, Schwaiger M, Arzbaecher RC. PMID: 1748443.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    163. A reusable perfusion supporting tissue-mimicking material for ultrasound hyperthermia phantoms. Med Phys. 1990 May-Jun; 17(3):380-90. Chin RB, Madsen EL, Zagzebski JA, Jadvar H, Wu XK, Frank GR. PMID: 2385195.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    164. Utility of a stimulus artifact suppressor for transesophageal pacing. Am J Cardiol. 1990 Feb 01; 65(5):393-4. Benson DW, Jadvar H, Strasburger JF. PMID: 2301269.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    165. The pill electrode. New technology as an adjunct to nursing assessment of patient arrhythmias. Prog Cardiovasc Nurs. 1989 Jan-Mar; 4(1):10-7. Quaal SJ, Phillips B, Howery T, Jadvar H. PMID: 2704730.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    166. A system for simultaneous esophageal atrial pacing and ventricular recording in computer analysis of posterior ischemia. J Electrocardiol. 1989; 22 Suppl:248-52. Jadvar H, Jenkins JM, Arzbaecher RC. PMID: 2614309.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    167. Computer processing of the electrocardiogram during transesophageal atrial pacing-induced stress. J Electrocardiol. 1987 Oct; 20 Suppl:106-7. Jadvar H, Jenkins JM, Hsia PW, Arzbaecher RC. PMID: 3694087.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    168. Lead configurations in esophageal electrocardiography. Med Instrum. 1987 Jun; 21(3):158-65. Jadvar H, Jenkins JM. PMID: 3614038.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Hossein's Networks
    Concepts (430)
    Derived automatically from this person's publications.
    _
    Co-Authors (48)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _